GB Olympic Gold Medallist Plays it Safe with Mole Screening 

Olympic rower, Will Satch, who earned a gold medal for Team GB in the Men’s Eights at the Rio 2016 Olympics, found time in between training sessions to access ScreenCancer’s Mole Screening Service, available in selected Alphega Pharmacies.

Skin cancer is now the most common form of cancer in the UK*. In 2012, more than 2,000 people died from malignant melanomas**. Skin cancer can affect people of all ages, but some are at a higher risk than others of developing a malignant melanoma (a type of skin cancer).

GB Gold Medallist Will Satch - Mole screening at alphega pharmacy

Those people most at risk include people with fair skin that burns easily, lots of moles or freckles, red or fair hair, anyone who was frequently sunburnt as a child or has a family history of skin cancer. Patients being treated with immunosuppressive drugs are also at higher risk of developing a melanoma.

 
"I got my results directly from ScreenCancer and have recommended the service to friends and GB teammates"
Will Satch - GB Gold Medallist
 
Will recently heard about ScreenCancer’s Mole Screening Service from a family member and, finding a rare break from training, he decided to use the service due to its convenience and accessibility. Prior to flying out to Rio to compete at the 2016 Olympic Games, Will visited Wraysbury Village Pharmacy in Staines, Middlesex, which is an Alphega Pharmacy member, to have images taken of two moles which were causing him concern.
 
Will Satch, 27, states: “There is very low awareness of the risks of skin cancer or how to spot it. I’ve been meaning to get the moles looked at but unfortunately hadn’t found the time to visit my GP. The Mole Screening Service, available in selected Alphega pharmacies, is a great initiative, primarily because people like me who have busy schedules can easily get checked. I got my results directly from ScreenCancer quickly and have recommended the service to friends and GB teammates.”
 
The most common sign of a malignant melanoma is the appearance of a new mole or a change in an existing mole. Areas of the body exposed to the sun are most affected. The most common place for a melanoma to develop is on the lower leg for women and on the back for men.
 
"There is very low awareness of the risks of skin cancer or how to spot it. I’ve been meaning to get the moles looked at but unfortunately hadn’t found the time to visit my GP."
Will Satch - GB Gold Medallist
 
The Mole Screening Service is provided by ScreenCancer is available at selected Alphega pharmacies. The service involves an image being taken of a mole(s) on the patient’s body using innovative imaging technology provided by ScreenCancer, and this image is then transmitted to a qualified ScreenCancer dermatologist for analysis. Getting your moles scanned is non-invasive, painless and quick.
 
Will Satch - Alphega Pharmacy Mole Scanning
 
Pharmacist at Wraysbury Village Pharmacy, Julie Tullett advises: “Anyone who is worried about a mole should get it checked straight away. The ScreenCancer Mole Screening Service is a fantastic way for anyone to check a mole they are concerned about. With this service, if something is identified as being suspicious, a ScreenCancer Dermatology Nurse contacts the customer with information about the image, provided by the dermatologist, and, if appropriate, gives the customer advice on the referral process, should further investigation be required.”
 
The mole scan costs just £35 for the first mole, then a further £15 per additional mole which is significantly cheaper than visiting a private dermatologist.
 
 
 
* Cancer Research UK
**Cancer Research UK
 
About ScreenCancer’s Mole Screening Service
The Mole Screening Service provided by ScreenCancer via selected Alphega pharmacies, involves scanning mole(s) on the customer’s body, using innovative imaging technology.
 
The scan takes place in a private room; it is non-invasive, painless and quick to perform. The images of the moles are taken in the pharmacy using a ScreenCancer SIAscope – an imaging device which emits light that penetrates 2mm below the surface of the skin. One scan provides five different multi-coloured images that reflect the depth and shape of the mole.
 
The scan is then sent to a ScreenCancer UK Dermatology Specialist for assessment. Within two weeks, ScreenCancer will provide a written report directly to the customer which gives advice about the moles and, if they are deemed suspicious, will recommend that the patient visits their GP for further investigation. It is important to note that the service cannot diagnose skin cancer or any other skin condition.
 
Mole Scanning Pharmacy - Pharmacy Near Me
More information: Mole Screening Service
 
Pharmacy Near Me - Alphega Pharmacy UK
Find: Mole Screening Pharmacies